Airfreight exports of NZ respiratory products boomed in March - AIA
Airfreighted exports of respiratory products shot higher in March, AIA says.
AdvertisementAdvertise with NZME.
Latest fromFisher and Paykel Healthcare
Continuous Disclosure: Why investors are lining up for NZ recapitalisation plans
Plus, is Sky City next in line to raise capital?
Continuous Disclosure: Sharemarket's biggest company keeps going up
Plus, Heartland shareholders still waiting for clarity.
F&P Healthcare shares rally sharply after earnings upgrade
F&P Healthcare's respiratory products are used in treating patients with coronavirus.
F&P Healthcare shares spike after earnings upgrade
Firm expects full year operating revenue to be $1.17b for net profit of about $245m-$255m.
'Colour Your Day' movement takes off after mosque shootings
Initiative aims to lift New Zealanders' spirits on Friday.
F&P Healthcare shares rally after deal with arch-rival
The fight has cost millions of dollars and spanned the globe.
F&P Healthcare hits record interim profit of $97.4 million
Net profit rose 20 per cent from a year ago.
F&P Healthcare to take $5-10M hit in patent stoush
Fisher & Paykel Healthcare is going toe to toe with rival ResMed.
Market has priced FPH at perfection, say analysts
Shares in Fisher & Paykel Healthcare fell slightly, despite another record result.
F&P Healthcare posts record result, nears $1 billion revenue
Fisher & Paykel Healthcare has posted another record result
F&P Healthcare boosts profits
Annual profit is likely to be between $185 million and $190 million.
F&P Healthcare wins patent case against ResMed
F&P Healthcare wins patent case against ResMed in UK Court.
Soaring Kiwi tech sector tops $10b of revenue: report
NZ tech companies have recorded over $10 billion in revenue for the first time.
F&P Healthcare may appeal ruling on Resmed
The ruling in Germany says ResMed did not infringe its patents.
Mercury leads sharemarket higher
NZ Refining stock falls amid pipeline repiar, while Synlait retreats from high.
F&P Healthcare lowers guidance on strong NZD
Fisher & Paykel Healthcare lowered full year earnings guidance due to the strong NZ dollar
F&P Healthcare boss sells shares to buy house
Lewis Gradon sold almost half of his shares, raising about $3.1 million to buy a house.
Embracing governance issues
COMMENT: Companies with higher ESG ratings are, on average, outperforming their peers.
Macquarie lifts F&P price target by 7.3pc
Macquarie Group lifted its 12-month target price on F&P Healthcare by 7.3 per cent
F&P Healthcare positive about future
Profit rose to a record $169m in the 12 months ended March 31, from $143m a year earlier.
Do young companies need a board to grow?
COMMENT: Problems can rise in scaling start-ups into a larger sustainable company.
F&P's new boss, just like the old boss
Business as usual is delivering results for healthcare company's chief executive.
SFO charges former F&P Healthcare manager
Former F&P healthcare manager pleads guilty to charges.
Improving board effectiveness
COMMENT: Boardroom conversation is an art form for some and a learned skill for others.
F&P's cunning plan to avoid Trump's tax
US President plans a 20% tax on goods from Mexico, where F&P Healthcare manufactures medical equipment, but the Kiwi company has a work-around.
Are directors performing at their best?
COMMENT: Governance cannot be that bad, given the growing interest in directorships from many individuals.
Former F&P Healthcare boss wins top award
Michael Daniell has won the New Zealand Shareholders Association's 2016 Beacon Award
F&P Healthcare posts 26pc gain
Fisher & Paykel Healthcare, the medical device maker, increased first-half profit 26 per cent and widened its margins.